GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipher Pharmaceuticals Inc (TSX:CPH) » Definitions » Cyclically Adjusted PS Ratio

Cipher Pharmaceuticals (TSX:CPH) Cyclically Adjusted PS Ratio : 7.61 (As of May. 22, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Cipher Pharmaceuticals Cyclically Adjusted PS Ratio?

As of today (2025-05-22), Cipher Pharmaceuticals's current share price is C$12.10. Cipher Pharmaceuticals's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was C$1.59. Cipher Pharmaceuticals's Cyclically Adjusted PS Ratio for today is 7.61.

The historical rank and industry rank for Cipher Pharmaceuticals's Cyclically Adjusted PS Ratio or its related term are showing as below:

TSX:CPH' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.39   Med: 2.95   Max: 27.31
Current: 7.8

During the past years, Cipher Pharmaceuticals's highest Cyclically Adjusted PS Ratio was 27.31. The lowest was 0.39. And the median was 2.95.

TSX:CPH's Cyclically Adjusted PS Ratio is ranked worse than
88.87% of 737 companies
in the Drug Manufacturers industry
Industry Median: 2.05 vs TSX:CPH: 7.80

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Cipher Pharmaceuticals's adjusted revenue per share data for the three months ended in Mar. 2025 was C$0.658. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is C$1.59 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Cipher Pharmaceuticals Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Cipher Pharmaceuticals's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cipher Pharmaceuticals Cyclically Adjusted PS Ratio Chart

Cipher Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.79 1.35 2.63 3.72 9.27

Cipher Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.94 5.47 10.06 9.27 8.03

Competitive Comparison of Cipher Pharmaceuticals's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Cipher Pharmaceuticals's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cipher Pharmaceuticals's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cipher Pharmaceuticals's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cipher Pharmaceuticals's Cyclically Adjusted PS Ratio falls into.


;
;

Cipher Pharmaceuticals Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Cipher Pharmaceuticals's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=12.10/1.59
=7.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cipher Pharmaceuticals's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Cipher Pharmaceuticals's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.658/129.1809*129.1809
=0.658

Current CPI (Mar. 2025) = 129.1809.

Cipher Pharmaceuticals Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.413 100.500 0.531
201509 0.426 100.421 0.548
201512 0.506 99.947 0.654
201603 0.346 101.054 0.442
201606 0.409 102.002 0.518
201609 0.382 101.765 0.485
201612 0.287 101.449 0.365
201703 0.403 102.634 0.507
201706 0.490 103.029 0.614
201709 0.460 103.345 0.575
201712 0.580 103.345 0.725
201803 0.219 105.004 0.269
201806 0.338 105.557 0.414
201809 0.233 105.636 0.285
201812 0.313 105.399 0.384
201903 0.254 106.979 0.307
201906 0.274 107.690 0.329
201909 0.284 107.611 0.341
201912 0.289 107.769 0.346
202003 0.305 107.927 0.365
202006 0.236 108.401 0.281
202009 0.233 108.164 0.278
202012 0.287 108.559 0.342
202103 0.252 110.298 0.295
202106 0.275 111.720 0.318
202109 0.212 112.905 0.243
202112 0.286 113.774 0.325
202203 0.261 117.646 0.287
202206 0.274 120.806 0.293
202209 0.250 120.648 0.268
202212 0.261 120.964 0.279
202303 0.262 122.702 0.276
202306 0.273 124.203 0.284
202309 0.320 125.230 0.330
202312 0.266 125.072 0.275
202403 0.326 126.258 0.334
202406 0.296 127.522 0.300
202409 0.547 127.285 0.555
202412 0.645 127.364 0.654
202503 0.658 129.181 0.658

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cipher Pharmaceuticals  (TSX:CPH) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Cipher Pharmaceuticals Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Cipher Pharmaceuticals's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cipher Pharmaceuticals Business Description

Traded in Other Exchanges
Address
5750 Explorer Drive, Suite 404, Mississauga, ON, CAN, L4W 0A9
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company is building its business through product acquisitions, out-licensing and in-licensing arrangements. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products among others. The company's geographical operational areas include Canada and the United States.
Executives
Harold Morton Wolkin Director
Christian Godin Director
Bryan Jacobs Senior Officer
Scott Langille Senior Officer
Nadine Jutlah Senior Officer
Arthur Marie Joseph Ghislain Deboeck Director
Mark Beaudet Director

Cipher Pharmaceuticals Headlines

No Headlines